Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
27 May 2014 European Medicines Agency Recommends to Extend Indications for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
26 May 2014 European Medicines Agency Recommends to Refuse a Change to the Marketing Authorisation for Bevacizumab Central nervous system malignancies - Anticancer agents & Biologic therapy
23 May 2014 European Medicines Agency Recommends Granting a Marketing Authorisation for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
21 May 2014 Study Calls for Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer Cancer in Special Situations
20 May 2014 A Mathematical Biologist Against Cancer Translational research - Central nervous system malignancies - Lung and other thoracic tumours
19 May 2014 New Science of Toxgnostics Personalised medicine - Anticancer agents & Biologic therapy
13 May 2014 Hypertension Related to VEGF Inhibitors Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Combination of mTOR and AKT Inhibitors in Patients with Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Molecular Subtype of a Breast Cancer Relapse Influences Patient Post-Relapse Survival Breast cancer - Pathology/Molecular biology - Translational research
09 May 2014 IMPAKT 2014 News: Adoption of Multi-gene Assays in Hormone Receptor-Positive, HER2-Negative Breast Cancer Breast cancer - Personalised medicine
09 May 2014 IMPAKT 2014 News: Therapeutic Effect and Markers of Response of Palbociclib in HER2-Positive Breast Cancer Models Breast cancer - Translational research - Anticancer agents & Biologic therapy
09 May 2014 IMPAKT 2014 News: Enzalutamide With or Without an Aromatase Inhibitor for Advanced Breast Cancer Breast cancer - Translational research
07 May 2014 Molecular Tumour Board Helps in Advanced Cancer Cases Personalised medicine
06 May 2014 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Denosumab Genitourinary cancers - Palliative and supportive care
05 May 2014 Withdrawal of Application for EMA Change to the Marketing Authorisation of Pazopanib Gynaecologic malignancies - Anticancer agents & Biologic therapy